A new “How Do We…?” feature in #Transfusion explores seven scenarios to help transfusion services develop SOPs tailored to their setting.
Read the open-access article: bit.ly/3IjLcev
A new “How Do We…?” feature in #Transfusion explores seven scenarios to help transfusion services develop SOPs tailored to their setting.
Read the open-access article: bit.ly/3IjLcev
🕛 12–4 p.m. ET | 📍 Virtual
🔗 bit.ly/4jF0vex
🕛 12–4 p.m. ET | 📍 Virtual
🔗 bit.ly/4jF0vex
AABB, in collaboration with the International Collaboration for Transfusion Medicine Guidelines, has released new evidence-based guidelines for platelet transfusion.
See the recommendations: bit.ly/45tCyU7
AABB, in collaboration with the International Collaboration for Transfusion Medicine Guidelines, has released new evidence-based guidelines for platelet transfusion.
See the recommendations: bit.ly/45tCyU7
AABB is proud to support EMS services working with hospitals and blood centers to expand prehospital blood transfusion programs through new standards and accreditation.
Thanks for all you do!
AABB is proud to support EMS services working with hospitals and blood centers to expand prehospital blood transfusion programs through new standards and accreditation.
Thanks for all you do!
Our new Annals piece warns why this shift could endanger blood safety, amplify misinformation, and erode public trust.
Read: www.acpjournals.org/doi/10.7326/...
#BloodSafety #Bioethics #Misinformation
Our new Annals piece warns why this shift could endanger blood safety, amplify misinformation, and erode public trust.
Read: www.acpjournals.org/doi/10.7326/...
#BloodSafety #Bioethics #Misinformation
Our new Standards for Emergency Prehospital and Scheduled Out-of-Hospital Transfusions provide comprehensive standards to support safe, high-quality transfusion care beyond the hospital.
Learn more: bit.ly/4iYcofn
Our new Standards for Emergency Prehospital and Scheduled Out-of-Hospital Transfusions provide comprehensive standards to support safe, high-quality transfusion care beyond the hospital.
Learn more: bit.ly/4iYcofn
After surviving lymphoma with CAR T-cell therapy, Sonia Su launched Kits to Heart to support others facing cancer. Her story is an important reminder of the impact of biotherapies and the power of kindness. 💙 bit.ly/3SyMR1v
After surviving lymphoma with CAR T-cell therapy, Sonia Su launched Kits to Heart to support others facing cancer. Her story is an important reminder of the impact of biotherapies and the power of kindness. 💙 bit.ly/3SyMR1v
Submit an abstract for #AABB2025 by May 19: bit.ly/2Nwn1NT
Submit an abstract for #AABB2025 by May 19: bit.ly/2Nwn1NT
Lab professionals are the quiet force driving innovation in transfusion medicine and biotherapies, from donor testing to patient care. Your precision, dedication and behind-the-scenes brilliance save lives every day.
Lab professionals are the quiet force driving innovation in transfusion medicine and biotherapies, from donor testing to patient care. Your precision, dedication and behind-the-scenes brilliance save lives every day.
Traumatically injured women are less likely to receive low-titer group O whole blood (LTOWB) transfusions within the first four hours of injury compared with traumatically injured men, according to research from investigators from @PittDeptofMed. bit.ly/4igOrzz
Traumatically injured women are less likely to receive low-titer group O whole blood (LTOWB) transfusions within the first four hours of injury compared with traumatically injured men, according to research from investigators from @PittDeptofMed. bit.ly/4igOrzz
AABB is offering a 10% discount on single-viewer eCasts and select publications and professional development programs from April 20-26. Use the code LABWEEK25 in the AABB Store. bit.ly/4lxMWzU
AABB is offering a 10% discount on single-viewer eCasts and select publications and professional development programs from April 20-26. Use the code LABWEEK25 in the AABB Store. bit.ly/4lxMWzU
In @aabbupdates.bsky.social journal, co-authors and I argue that guidelines should come with an intentional plan for real-world uptake. We leverage #ImplementationScience to outline a process for doing so
onlinelibrary.wiley.com/doi/10.1111/...
In @aabbupdates.bsky.social journal, co-authors and I argue that guidelines should come with an intentional plan for real-world uptake. We leverage #ImplementationScience to outline a process for doing so
onlinelibrary.wiley.com/doi/10.1111/...
Listen to the episode and join the discussion: bit.ly/4cixmUB
Listen to the episode and join the discussion: bit.ly/4cixmUB
Read more: bit.ly/4j5RRGi
Read more: bit.ly/4j5RRGi
Findings from the 2023 National Blood Collection and Utilization Survey suggest continued stabilization of the U.S. blood supply.
Check out highlights from the 2023 survey: bit.ly/4iZTCEY
Findings from the 2023 National Blood Collection and Utilization Survey suggest continued stabilization of the U.S. blood supply.
Check out highlights from the 2023 survey: bit.ly/4iZTCEY
Read more: bit.ly/3XMEmTC
#BloodDonation
Read more: bit.ly/3XMEmTC
#BloodDonation
A new AABB News feature explores how leaders at South Texas Blood & Tissue, the San Antonio Fire Department, Northwestern Medicine and Aurora Health strengthened disaster preparedness plans at their institutions. bit.ly/3EXyL6r
A new AABB News feature explores how leaders at South Texas Blood & Tissue, the San Antonio Fire Department, Northwestern Medicine and Aurora Health strengthened disaster preparedness plans at their institutions. bit.ly/3EXyL6r
In a new “White Coats” interview, Bill Block, president and CEO of Blood Centers of America, shares how blood centers can mitigate risk and strengthen supply chain security.
Read more in AABB News: bit.ly/4gUUZDs
In a new “White Coats” interview, Bill Block, president and CEO of Blood Centers of America, shares how blood centers can mitigate risk and strengthen supply chain security.
Read more in AABB News: bit.ly/4gUUZDs
Learn about #cordblood from the experts. buff.ly/40QlSUd
#AZCBC25 #AZPublicCordBlood
Learn about #cordblood from the experts. buff.ly/40QlSUd
#AZCBC25 #AZPublicCordBlood
suggests that rare secondary malignancies after CAR T-cell therapy may stem from prior cancer treatments—not the CAR T-cell therapies. Learn more: bit.ly/412TXR7 #CellularTherapy
suggests that rare secondary malignancies after CAR T-cell therapy may stem from prior cancer treatments—not the CAR T-cell therapies. Learn more: bit.ly/412TXR7 #CellularTherapy